|1.||WO||WO/2014/199109 - VEHICLE SEAT ASSEMBLY||18.12.2014||
|PCT/GB2013/053060||NISSAN MOTOR MANUFACTURING (UK) LTD||PAGETT, Mark|
A seat adjustment mechanism for providing fore-aft adjustment of a vehicle seat is provided. The adjustment mechanism comprises a runner for rigid fixing to the vehicle floor and a slider for rigid fixing to a frame of the seat. The slider is arranged for cooperating with the runner to provide fore-aft adjustment of a position of the vehicle seat, and the runner is inclined upwardly towards the rear of the vehicle.
|2.||WO||WO/2014/199118 - SECURITY PROTECTION OF SOFTWARE LIBRARIES IN A DATA PROCESSING APPARATUS||18.12.2014||
|PCT/GB2014/050747||ARM LIMITED||GROCUTT, Christopher, Thomas|
A processing apparatus (2) has a secure domain (90) and a less secure domain (80). Security protection hardware (40) performs security checking operations when the processing circuitry (2) calls between domains. A data store (6) stores several software libraries (100) and library management software (110). The library management software (110) selects at least one of the libraries (100) as an active library which is executable by the processing circuitry (4) and at least one other library (100) as inactive libraries which are not executable. In response to an access to an inactive library, the library management software (110) switches which library is active.
|3.||WO||WO/2014/199119 - METHOD FOR DETERMINING A PROBABILITY OF A MAJOR ADVERSE CARDIAC EVENT (MACE)||18.12.2014||
|PCT/GB2014/051250||THE UNIVERSITY OF MANCHESTER||BODY, Richard|
Embodiments of the present invention provide A method of determining a likelihood of a major adverse cardiac event (MACE) of a subject within a predetermined period of time, comprising determining a presence of electrocardiographic (ECG) ischemia of said subject, observing a presence of vomiting, sweating, hypotension and worsening angina of the subject, determining quantities of heart-type fatty acid binding protein (H-FABP) and troponin (Tn) in a sample taken from said subject, determining a probability value P indicative of a likelihood of a MACE of the subject within a predetermined period of time, wherein P is calculated based on the quantities of H-FABP and Tn and values indicative of the presence of each of the ECG ischemia, pain radiating to the right arm or shoulder, vomiting, sweating, hypotension and worsening angina of the patient.
|4.||WO||WO/2014/199128 - SYSTEM AND METHOD FOR ENCRYPTION||18.12.2014||
|PCT/GB2014/051749||CRYPTOMATHIC LTD||FORGET, Guillaume|
A method and system for generating a signature for a user are described. The system comprises a signature server, an initial transaction device for a user and a validation device for a user. The initial transaction device is configured to display a first message M and send a request to the signature server to create a signature for said first message M. The signature server is configured to generate a validation challenge using a second message M' which is based on said first message M' and a first secret shared between said user and said signature server and send said validation challenge to the validation device. The validation device is configured to regenerate said second message M' using said first shared secret, display said second message M', receive user confirmation that the displayed second message M' corresponds to said first message M, generate a validation code confirming the request to create a signature; and send said validation code to said signature server. Thereafter, said signature server generates the signature for the user for the first message M.
|5.||WO||WO/2014/199123 - PROCESS GAS ABATEMENT||18.12.2014||
|PCT/GB2014/051631||EDWARDS LIMITED||SEELEY, Andrew James|
A process gas abatement apparatus and method are disclosed. The process gas abatement apparatus comprises: a burner comprising: a combustion chamber operable to receive an effluent gas stream from a manufacturing process tool to be treated within the combustion chamber at a sub-atmospheric pressure, the combustion chamber being further operable to receive a fuel, oxidant and diluent, the fuel, oxidant and diluent controlling combustion within the combustion chamber to treat the effluent gas stream to produce a treated exhaust stream, the diluent being condensable in the treated exhaust stream. By providing a diluent in the form of, for example, an inert condensable, the volume gain within the combustion chamber is reduced, which reduces the volume of the exhaust stream and reduces the volumetric load on the second pump. The volume gain reduces because the diluent shifts phase in the exhaust stream, thereby effectively removing the contribution of the diluent to the volume of the exhaust stream. This leads to considerable power saving since a lower volume of gas is output from the combustion chamber which would need to be brought up to the second pressure, for example atmospheric pressure, by means of the second pump.
|6.||WO||WO/2014/199124 - OBJECT-HANDLING DEVICE||18.12.2014||
||PCT/GB2014/051638||THE UNIVERSITY OF BRISTOL||MCKEOWN, Colm|
The present invention provides object-handling devices having a device body connected to a deformable object-contacting portion useful in moving objects, such as composite materials, from one location to another. Also provided are methods of handling an object using object-handling devices and object-handling assemblies including object-handling devices.
|7.||WO||WO/2014/199125 - CURABLE COMPOSITIONS AND MEMBRANES||18.12.2014||
|PCT/GB2014/051665||FUJIFILM MANUFACTURING EUROPE BV||ANTHEUNIS, Harro|
A composition comprising: a)5to 65wt% of curable compoundcomprising one ethylenically unsaturated group and at least one anionic group; b)2.5 to 70wt% of crosslinking agent comprising at least two acrylic groups; c)a tertiary amine; and d)0 to 45wt% of inert solvent; wherein the molar ratio of component c) to a) is at least 0.7. Also described are a process for making composite membranes and the resultant membranes.
|8.||WO||WO/2014/199126 - FIRE AND SMOKE CURTAIN||18.12.2014||
|PCT/GB2014/051678||COOPERS FIRE LTD||COOPER, Andrew Paul|
A barrier comprising a roller, a curtain 2, a bottom bar and a friction brake. The curtain arrangement 1 includes a curtain 2, which when not deployed is wound on a roller 4. The roller is provided within a headbox 6, in a ceiling 8. The curtain is provided with a bottom bar 10 which weighs the curtain for descent, but can also be used to close the headbox when the curtain is retracted onto the roller. Side guides 12 are also provided to contain side edges 14 of the curtain. They extend from the headbox 6 on the ceiling to the floor 18. The curtain is held in its retracted position on the roller, by a fusible link 20. An extension 22 of the roller 2 is provided extending out of the headbox 6. The fusible link 20 is provided between the outside of the headbox and the extension 22 of the roller. A peg 24 mounted on the headbox 6 holds one portion 26 of the fusible link, while the other portion 28 of the fusible link is connected to the extension. These portions are held together by a material 30 having a low melting point range typically between 57-150°C. This acts to hold the curtain on the roller under normal condition, preventing rotation of the roller within the headbox, but on sufficient temperature rise, the material 30 will melt, releasing the portions 26, 28 of the fusible link, allowing rotation of the roller and deployment of the curtain.
|9.||WO||WO/2014/199114 - METHODS||18.12.2014||
|PCT/GB2014/000233||MARS INCORPORATED||McGRANE, Scott Jospeph|
The present invention relates to a method of identifying a compound that binds to or modulates the activity of one or more polypeptides encoding one or more receptors that are involved in the detection and perception of fatty acids.
|10.||WO||WO/2014/199115 - ASSAY AND METHOD||18.12.2014||
|PCT/GB2014/000234||MARS, INCORPORATED||HARRIS, Stephen James|
The present invention relates to an assay for use in a method of determining the oral health status of a canine animal by identifying certain bacteria present or absent in a sample taken from the animal, and applying the information set out herein for each identified bacteria to statistical models in order to determine the oral health status of the animal.